HYPOXIA INDUCIBLE VEGF PRODUCTION IN SLEEP APNEA
睡眠呼吸暂停中缺氧诱导的 VEGF 产生
基本信息
- 批准号:6644868
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Angiogenesis is the physiological adaptive response of a tissue to hypoxia.
The coronary collateral circulation of the heart represents such an adaptive
response and is an important determinant in the extent of tissue damage
following myocardial infarction. Autopsy studies have shown that only 50
percent of patients with coronary artery stenosis develop collaterals. A
fundamental challenge in understanding the angiogenic response to ischemia in
the clinical setting is to elucidate the basis for interindividual differences
in the degree of collateral blood vessel formation. Recent evidence
demonstrates the importance of differences between patients in the hypoxic
regulation of the angiogenic growth factor, vascular endothelial growth factor
(VEGF) in determining the extent of collateral blood vessel formation.
Specifically, individuals who upregulate VEGF to a greater degree with hypoxia
have more collateral blood vessels. The investigators intend to investigate
the mechanism for this heterogeneity in the hypoxic regulation of VEGF.
Accordingly, the specific aims of this project are: (1) Analysis of
interindividual heterogeneity in hypoxia-inducible VEGF production in patients
with obstructive sleep apnea syndrome (OSAS) in vivo and in vitro and its
relationship to coronary collaterals; (2) Determination of the molecular
mechanism for interindividual heterogeneity in VEGF production in response to
hypoxia. These studies may lead to the development of new strategies to
increase VEGF production in the setting of ischemic heart disease and thereby
promote therapeutic angiogenesis. In addition, understanding the mechanism of
interindividual heterogeneity in VEGF production in response to hypoxia would
be of tremendous importance for understanding and predicting the natural
history of a wide variety of diseases involving VEGF including tumor
angiogenesis, diabetic retinopathy, rheumatoid arthritis, and inflammatory
bowel disease.
血管生成是组织对缺氧的生理适应性反应。
心脏的冠状动脉侧支循环代表了这样一种适应性
是组织损伤程度的重要决定因素
心肌梗死后。 尸检研究表明,
%的冠状动脉狭窄患者出现侧支循环。 一
了解缺血性心脏病血管生成反应的基本挑战
临床背景是阐明个体间差异的基础,
侧支血管形成的程度。 最近的证据
证明了患者之间在缺氧的重要性差异,
调节血管生成生长因子、血管内皮生长因子
血管内皮生长因子(VEGF)在确定侧支血管形成的程度。
具体来说,缺氧时VEGF上调程度更高的个体
有更多的侧支血管 调查人员打算调查
这种异质性的机制在缺氧调节VEGF。
因此,本项目的具体目标是:(1)分析
患者缺氧诱导VEGF产生的个体间异质性
阻塞性睡眠呼吸暂停综合征(OSAS)的体内和体外研究,
与冠状动脉侧支的关系;(2)分子水平的测定
VEGF产生的个体间异质性机制
缺氧 这些研究可能会导致制定新的战略,
增加缺血性心脏病背景下VEGF的产生,
促进治疗性血管生成。 此外,了解
缺氧反应中VEGF产生的个体间异质性,
对于理解和预测自然界中
多种涉及VEGF的疾病史,包括肿瘤
血管生成、糖尿病视网膜病变、类风湿性关节炎和炎性
肠道疾病。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome.
结合珠蛋白多态性是阻塞性睡眠呼吸暂停综合征患者心血管疾病的危险因素。
- DOI:10.1093/sleep/26.5.592
- 发表时间:2003
- 期刊:
- 影响因子:5.6
- 作者:Lavie,Lena;Lotan,Rachel;Hochberg,Irit;Herer,Paula;Lavie,Peretz;Levy,AndrewP
- 通讯作者:Levy,AndrewP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW Peter LEVY其他文献
ANDREW Peter LEVY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW Peter LEVY', 18)}}的其他基金
Oxidation Hypothesis Revisited: Haptoglobin Genotype & Diabetic Atherosclerosis
重新审视氧化假说:触珠蛋白基因型
- 批准号:
8288593 - 财政年份:2009
- 资助金额:
$ 12.5万 - 项目类别:
The Oxidation Hypothesis Revisited:Haptoglobin Genotype and Diabetic Atherosclero
重温氧化假说:结合珠蛋白基因型与糖尿病动脉粥样硬化
- 批准号:
7582609 - 财政年份:2009
- 资助金额:
$ 12.5万 - 项目类别:
Oxidation Hypothesis Revisited: Haptoglobin Genotype & Diabetic Atherosclerosis
重新审视氧化假说:触珠蛋白基因型
- 批准号:
8516953 - 财政年份:2009
- 资助金额:
$ 12.5万 - 项目类别:
Oxidation Hypothesis Revisited: Haptoglobin Genotype & Diabetic Atherosclerosis
重新审视氧化假说:触珠蛋白基因型
- 批准号:
8111696 - 财政年份:2009
- 资助金额:
$ 12.5万 - 项目类别:
The Oxidation Hypothesis Revisited:Haptoglobin Genotype and Diabetic Atherosclero
重温氧化假说:结合珠蛋白基因型与糖尿病动脉粥样硬化
- 批准号:
7826728 - 财政年份:2009
- 资助金额:
$ 12.5万 - 项目类别:
HYPOXIA INDUCIBLE VEGF PRODUCTION IN SLEEP APNEA
睡眠呼吸暂停中缺氧诱导的 VEGF 产生
- 批准号:
6230020 - 财政年份:2000
- 资助金额:
$ 12.5万 - 项目类别:
HYPOXIA INDUCIBLE VEGF PRODUCTION IN SLEEP APNEA
睡眠呼吸暂停中缺氧诱导的 VEGF 产生
- 批准号:
6390949 - 财政年份:2000
- 资助金额:
$ 12.5万 - 项目类别:
HYPOXIA INDUCIBLE VEGF PRODUCTION IN SLEEP APNEA
睡眠呼吸暂停中缺氧诱导的 VEGF 产生
- 批准号:
6527686 - 财政年份:2000
- 资助金额:
$ 12.5万 - 项目类别:
HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR
血管内皮生长因子的缺氧调节
- 批准号:
2211661 - 财政年份:1995
- 资助金额:
$ 12.5万 - 项目类别:
HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR
血管内皮生长因子的缺氧调节
- 批准号:
2519200 - 财政年份:1995
- 资助金额:
$ 12.5万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 12.5万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别: